4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-25-032197
EVP, COO acquired 5 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. EVP, COO | 2025-03-02 | Option exercise | +3 | 34 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2025-03-03 | Option exercise | +2 | 36 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2025-03-02 | Option exercise · Restricted Stock Unit | −3 | 4 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2025-03-03 | Option exercise · Restricted Stock Unit | −2 | 0 | D | ||
Loading xslF345X05/ownership.xml…